cyclandelate has been researched along with isoxsuprine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (70.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Coffman, JD | 3 |
| Berger, PA; Hollister, LE; Tinklenberg, JR; Yesavage, JA | 1 |
| Miyazaki, M | 1 |
| Offerhaus, L | 1 |
3 review(s) available for cyclandelate and isoxsuprine
| Article | Year |
|---|---|
Drug therapy: vasodilator drugs in peripheral vascular disease.
Topics: Cyclandelate; Ethanol; Guanethidine; Humans; Isoxsuprine; Methyldopa; Nicotinic Acids; Nylidrin; Papaverine; Reserpine; Sympathetic Nervous System; Tolazoline; Vascular Diseases; Vasodilator Agents | 1979 |
Vasodilator drugs in peripheral vascular disease.
Topics: Animals; Arterial Occlusive Diseases; Cyclandelate; Ergot Alkaloids; Humans; Ischemia; Isoxsuprine; Methyldopa; Nicotinic Acids; Nylidrin; Papaverine; Regional Blood Flow; Reserpine; Tolazoline; Vascular Diseases; Vasodilator Agents | 1975 |
Vasodilator drugs in peripheral vascular disease.
Topics: Arterial Occlusive Diseases; Cyclandelate; Ergot Alkaloids; Ethanol; Guanethidine; Humans; Ischemia; Isoxsuprine; Methyldopa; Nicotinic Acids; Nylidrin; Papaverine; Research Design; Reserpine; Sympathetic Nervous System; Tolazoline; Vascular Diseases; Vasodilator Agents | 1975 |
7 other study(ies) available for cyclandelate and isoxsuprine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Vasodilators in senile dementias: a review of the literature.
Topics: Aged; Cinnarizine; Cyclandelate; Dementia; Dihydroergotoxine; Drug Evaluation; Humans; Isoxsuprine; Mental Processes; Nafronyl; Papaverine; Pyrithioxin; Vasodilator Agents | 1979 |
Circulatory effect of several cerebral circulatory drugs in man, with special reference to aminophylline, papaverine, cyclandelate, vincamine, prostaglandin E1 and isoxsuprine.
Topics: Aged; Aminophylline; Blood Circulation; Brachial Artery; Carotid Arteries; Cerebrovascular Circulation; Cyclandelate; Humans; Isoxsuprine; Male; Mandelic Acids; Middle Aged; Papaverine; Prostaglandins E; Ultrasonography; Vinca Alkaloids; Vincamine | 1978 |
Drugs for dementia.
Topics: Aged; Cyclandelate; Dementia; Dihydroergotoxine; Female; Humans; Isoxsuprine; Male; Meclofenoxate; Middle Aged; Nafronyl; Nicotinic Acids; Theobromine; Vasodilator Agents; Xanthinol Niacinate | 1975 |
[Indications for and effects of vasodilating agents, especially in cerebral and peripheral vascular sclerosis].
Topics: Aged; Arterial Occlusive Diseases; Cerebrovascular Disorders; Cyclandelate; Dihydroergotoxine; Female; Humans; Isoxsuprine; Leg; Male; Vasodilator Agents | 1981 |